Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037240
Filing Date
2020-08-06
Accepted
2020-08-06 07:15:57
Documents
86
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-10q_20200630.htm 10-Q 2590488
2 EX-10.1 itrm-ex101_268.htm EX-10.1 280859
3 EX-10.2 itrm-ex102_267.htm EX-10.2 265238
4 EX-31.1 itrm-ex311_6.htm EX-31.1 19642
5 EX-31.2 itrm-ex312_9.htm EX-31.2 19951
6 EX-32.1 itrm-ex321_8.htm EX-32.1 10660
7 EX-32.2 itrm-ex322_7.htm EX-32.2 10537
  Complete submission text file 0001564590-20-037240.txt   10410018

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT itrm-20200630.xml EX-101.INS 2032613
9 XBRL TAXONOMY EXTENSION SCHEMA itrm-20200630.xsd EX-101.SCH 74644
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itrm-20200630_cal.xml EX-101.CAL 57210
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itrm-20200630_def.xml EX-101.DEF 314752
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20200630_lab.xml EX-101.LAB 532614
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20200630_pre.xml EX-101.PRE 489608
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 201079791
SIC: 2834 Pharmaceutical Preparations